Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Common-Stock-Shares-Outstanding" stands at 1.80 Billion Japanese Yens as of 06/30/2025.
As of the end of Astellas Pharma Inc.'s first quarter, the item "Common Stock Shares Outstanding" stands at 1.80 Billion JPY. This represents an increase of 0.29 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.0205 percent compared to the value the year prior.
The 1 year change in percent is -0.0205.
The 3 year change in percent is -1.67.
The 5 year change in percent is -3.40.
The 10 year change in percent is -18.11.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Common Stock Shares Outstanding | 905,699,262,464.00 |
![]() | Johnson & Johnson - Common Stock Shares Outstanding | 486,508,953,600.00 |
![]() | AbbVie Inc - Common Stock Shares Outstanding | 399,570,305,024.00 |
![]() | Roche Holding AG - Common Stock Shares Outstanding | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Common Stock Shares Outstanding | 280,205,508,085.11 |